☰

Matthew Brown, Ph.D/MD - Publications

Affiliations: 
University of Queensland, Saint Lucia, Queensland, Australia 
Tree Info Grants Similar researchers PubMed Report error

16 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Thaventhiran JED, Lango Allen H, Burren OS, Rae W, Greene D, Staples E, Zhang Z, Farmery JHR, Simeoni I, Rivers E, Maimaris J, Penkett CJ, Stephens J, Deevi SVV, Sanchis-Juan A, ... ... Brown M, et al. Whole-genome sequencing of a sporadic primary immunodeficiency cohort. Nature. PMID 32499645 DOI: 10.1038/S41586-020-2265-1  0.316
2016 Lawrence MJ, Marsden N, Kaczynski J, Davies G, Davies N, Hawkins K, Perumal S, Brown MR, Morris K, Davidson SJ, Williams PR, Evans PA. An Investigation Into the Effects of In Vitro Dilution With Different Colloid Resuscitation Fluids on Clot Microstructure Formation. Anesthesia and Analgesia. PMID 27636739 DOI: 10.1213/ANE.0000000000001536  0.453
2015 Davies NA, Harrison NK, Morris RH, Noble S, Lawrence MJ, D'Silva LA, Broome L, Brown MR, Hawkins KM, Williams PR, Davidson S, Evans PA. Fractal dimension (df) as a new structural biomarker of clot microstructure in different stages of lung cancer. Thrombosis and Haemostasis. 114. PMID 26293709 DOI: 10.1160/TH15-04-0357  0.457
2015 Lawrence MJ, Sabra A, Thomas P, Obaid DR, D'Silva LA, Morris RH, Hawkins K, Brown MR, Williams PR, Davidson SJ, Chase AJ, Smith D, Evans PA. Fractal dimension: A novel clot microstructure biomarker use in ST elevation myocardial infarction patients. Atherosclerosis. 240: 402-7. PMID 25890059 DOI: 10.1016/j.atherosclerosis.2015.04.012  0.454
2015 Stanford SN, Sabra A, D'Silva L, Lawrence M, Morris RH, Storton S, Brown MR, Evans V, Hawkins K, Williams PR, Davidson SJ, Wani M, Potter JF, Evans PA. The changes in clot microstructure in patients with ischaemic stroke and the effects of therapeutic intervention: a prospective observational study. Bmc Neurology. 15: 35. PMID 25885595 DOI: 10.1186/s12883-015-0289-1  0.445
2015 Lawrence MJ, Sabra A, Mills G, Pillai SG, Abdullah W, Hawkins K, Morris RH, Davidson SJ, D'Silva LA, Curtis DJ, Brown MR, Weisel JW, Williams PR, Evans PA. A new biomarker quantifies differences in clot microstructure in patients with venous thromboembolism. British Journal of Haematology. 168: 571-5. PMID 25302653 DOI: 10.1111/Bjh.13173  0.462
2014 Lawrence MJ, Kumar S, Hawkins K, Boden S, Rutt H, Mills G, Sabra A, Morris RH, Davidson SJ, Badiei N, Brown MR, Williams PR, Evans PA. A new structural biomarker that quantifies and predicts changes in clot strength and quality in a model of progressive haemodilution. Thrombosis Research. 134: 488-94. PMID 24965661 DOI: 10.1016/j.thromres.2014.05.039  0.44
2014 Ellinghaus D, Jostins L, Cortes A, Andreassen O, Wang Y, Spain S, Elder J, Trembath R, Barker J, Karlsen T, Dale A, McGovern D, Schreiber S, Brown M, Barrett J, et al. OP017 Cross-disease study determines extent of sharing of associated loci between five seronegative auto-inflammatory diseases Journal of Crohn's and Colitis. 8: S10. DOI: 10.1016/S1873-9946(14)60018-0  0.312
2013 Davidson SI, Jiang L, Cortes A, Wu X, Glazov EA, Donskoi M, Zheng Y, Danoy PA, Liu Y, Thomas GP, Brown MA, Xu H. Brief report: high-throughput sequencing of IL23R reveals a low-frequency, nonsynonymous single-nucleotide polymorphism that is associated with ankylosing spondylitis in a Han Chinese population. Arthritis and Rheumatism. 65: 1747-52. PMID 23606107 DOI: 10.1002/art.37976  0.46
2012 Kenna TJ, Davidson SI, Duan R, Bradbury LA, McFarlane J, Smith M, Weedon H, Street S, Thomas R, Thomas GP, Brown MA. Enrichment of circulating interleukin-17-secreting interleukin-23 receptor-positive γ/δ T cells in patients with active ankylosing spondylitis. Arthritis and Rheumatism. 64: 1420-9. PMID 22144400 DOI: 10.1002/art.33507  0.428
2012 Srivastava B, Mells GF, Cordell HJ, Muriithi A, Brown M, Ellinghaus E, Franke A, Karlsen TH, Sandford RN, Alexander GJ, Chapman RW, Rushbrook SM, Melum E. PTU-070 Fine mapping of the IL-2/IL-21 and IL2RA loci in primary sclerosing cholangitis Gut. 61. DOI: 10.1136/Gutjnl-2012-302514C.70  0.3
2012 Charlesworth J, Stankovich J, Lewis P, Byron J, Stevens W, Sahhar J, Proudman S, Roddy J, Nash P, Tymms K, Brown M, Zochling J. An immunochip-based interrogation of scleroderma susceptibility variants Rheumatology. 51: 15-16. DOI: 10.1093/Rheumatology/Ker505  0.305
2011 Davidson SI, Liu Y, Danoy PA, Wu X, Thomas GP, Jiang L, Sun L, Wang N, Han J, Han H, Visscher PM, Brown MA, Xu H. Association of STAT3 and TNFRSF1A with ankylosing spondylitis in Han Chinese. Annals of the Rheumatic Diseases. 70: 289-92. PMID 21068102 DOI: 10.1136/ard.2010.133322  0.45
2009 Davidson SI, Wu X, Liu Y, Wei M, Danoy PA, Thomas G, Cai Q, Sun L, Duncan E, Wang N, Yu Q, Xu A, Fu Y, Brown MA, Xu H. Association of ERAP1, but not IL23R, with ankylosing spondylitis in a Han Chinese population. Arthritis and Rheumatism. 60: 3263-8. PMID 19877036 DOI: 10.1002/art.24933  0.453
2008 Brown MA. Breakthroughs in genetic studies of ankylosing spondylitis Rheumatology. 47: 132-137. PMID 18037607 DOI: 10.1093/Rheumatology/Kem269  0.314
2004 Sims A, Wordsworth B, Brown M. Genetic susceptibility to ankylosing spondylitis. Current Molecular Medicine. 4: 13-20. PMID 15011955 DOI: 10.2174/1566524043479284  0.307
Show low-probability matches.